Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,HR[95%CI],P_value
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter I Certain infectious and parasitic diseases,"Bacterial infection, other or unspecified",18431,149,0.99 [0.74-1.32],0.94848638614773
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",19372,199,0.95 [0.73-1.24],0.7046757624783608
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",19140,1391,0.96 [0.87-1.06],0.4663075818086613
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter I Certain infectious and parasitic diseases,Candidiasis,19388,440,1.09 [0.94-1.26],0.2580598989152414
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,18742,3412,1.02 [0.97-1.09],0.4338936775867292
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),18732,3463,1.02 [0.96-1.08],0.5373920368847822
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter I Certain infectious and parasitic diseases,Diarrhoea and gastroenteritis of presumed infectious origin,19141,1146,1.04 [0.94-1.14],0.4951560686411433
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter I Certain infectious and parasitic diseases,Enterocolitis due to Clostridium difficile,19300,105,1.11 [0.81-1.51],0.5120789051731012
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,17106,1008,1.05 [0.95-1.17],0.3558901387996955
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,16479,1217,0.99 [0.89-1.09],0.7900515924447132
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter I Certain infectious and parasitic diseases,Implicit fungal Sepsis,16151,264,0.90 [0.70-1.14],0.3675433883344242
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,12636,2189,0.99 [0.92-1.07],0.8903902736699529
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,16098,389,0.95 [0.78-1.15],0.5750756126793961
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,19351,1356,1.02 [0.93-1.12],0.6063563760273797
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter I Certain infectious and parasitic diseases,Mycoses,19456,508,1.07 [0.92-1.23],0.373021282470469
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,18728,979,0.98 [0.87-1.10],0.7128930544467944
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,19398,1116,1.04 [0.94-1.15],0.4355860041780431
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,18194,199,0.95 [0.73-1.24],0.7221933928564945
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter I Certain infectious and parasitic diseases,Other infectious diseases,19505,49,1.45 [1.08-1.94],0.0134313291092373
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter I Certain infectious and parasitic diseases,Other septicaemia,19254,972,1.05 [0.94-1.17],0.4045563999306498
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,19257,62,0.95 [0.59-1.51],0.8192683852848275
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter I Certain infectious and parasitic diseases,Other viral diseases,19450,108,1.15 [0.87-1.53],0.3287545030086271
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",19435,93,1.06 [0.76-1.49],0.7371634507366507
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,18134,385,0.86 [0.70-1.05],0.1442506104296639
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter I Certain infectious and parasitic diseases,Viral agents as the cause of diseases classified to other chapters,17996,247,1.10 [0.90-1.34],0.345422523676801
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter I Certain infectious and parasitic diseases,Viral and other specified intestinal infections,18096,101,0.88 [0.59-1.31],0.5233664986301075
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter I Certain infectious and parasitic diseases,Viral hepatitis,19490,45,1.10 [0.69-1.74],0.684448332248679
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,19446,149,0.89 [0.65-1.23],0.4899952613985785
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter I Certain infectious and parasitic diseases,Viral warts,19346,49,1.29 [0.91-1.81],0.1513672198339958
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter I Certain infectious and parasitic diseases,Zoster [herpes zoster],19367,70,0.58 [0.32-1.06],0.0776215489590594
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter II Neoplasms,Benign lipomatous neoplasm,19265,220,0.79 [0.59-1.05],0.1079317588591131
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,19433,37,0.87 [0.46-1.66],0.679470906671964
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,19419,39,0.65 [0.30-1.40],0.2701881041839166
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter II Neoplasms,Benign lipomatous neoplasm of spermatic cord,9244,66,0.97 [0.63-1.50],0.9062818737262184
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",19118,1405,0.91 [0.82-1.00],0.0571817632712069
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter II Neoplasms,Benign neoplasm of meninges,19491,55,1.32 [0.97-1.81],0.0785877638531272
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,19423,69,0.84 [0.52-1.37],0.4864660520156006
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter II Neoplasms,Benign neoplasm of other and unspecified endocrine glands,19482,100,1.25 [0.96-1.62],0.1017596917097139
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter II Neoplasms,Benign neoplasm of ovary,10210,62,0.72 [0.41-1.26],0.2524905097400878
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter II Neoplasms,Benign neoplasm: Ascending colon,19471,380,0.92 [0.75-1.12],0.3891737057786922
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter II Neoplasms,Benign neoplasm: Caecum,19483,322,0.77 [0.60-0.98],0.0305136488190392
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",19381,72,0.93 [0.60-1.45],0.7627633072810739
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter II Neoplasms,Benign neoplasm: Descending colon,19469,218,0.90 [0.69-1.17],0.4255638644564564
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter II Neoplasms,Benign neoplasm: Rectum,19426,339,0.80 [0.64-1.01],0.0584259897149048
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,19376,589,1.00 [0.86-1.15],0.947972140934365
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter II Neoplasms,Benign neoplasm: Transverse colon,19463,447,0.90 [0.75-1.08],0.2614873883597246
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter II Neoplasms,Carcinoma in situ of breast,7686,45,1.28 [0.91-1.79],0.1513239904605545
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",7718,54,1.06 [0.71-1.61],0.7646695503919791
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",13994,60,1.04 [0.69-1.58],0.8353626795091794
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter II Neoplasms,"Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)",14018,84,0.97 [0.66-1.43],0.8859332154735488
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",19456,107,0.91 [0.63-1.31],0.6134024170543295
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter II Neoplasms,"Haemangioma, any site",19457,104,0.92 [0.64-1.33],0.6737257546807698
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter II Neoplasms,Leiomyoma of uterus,9978,146,1.06 [0.82-1.37],0.6400869081824544
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter II Neoplasms,Lung cancer and mesothelioma,12448,419,1.09 [0.92-1.31],0.3196582603285341
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter II Neoplasms,Lymphoid leukaemia,13996,62,0.99 [0.65-1.52],0.9681925277995148
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",14121,187,0.99 [0.76-1.27],0.9081414220812194
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",14190,256,0.94 [0.74-1.19],0.5887145619525787
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",7799,96,1.01 [0.71-1.43],0.965270831201966
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",14023,89,0.97 [0.66-1.42],0.8746216609582704
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter II Neoplasms,"Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)",14054,120,0.90 [0.63-1.29],0.5779368151084296
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter II Neoplasms,"Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)",14043,109,1.10 [0.81-1.49],0.5403898719618139
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",7783,80,0.96 [0.65-1.43],0.858721168418048
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter II Neoplasms,"Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)",14037,103,0.91 [0.63-1.33],0.631293149525987
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",7032,801,0.79 [0.67-0.91],0.0018741290666902
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter II Neoplasms,"Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)",14046,112,1.11 [0.83-1.48],0.4952494856080647
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter II Neoplasms,"Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)",14015,81,1.02 [0.69-1.51],0.909883287834556
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,14051,117,1.11 [0.84-1.47],0.4495215629659074
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter II Neoplasms,Melanocytic naevi,19384,155,0.98 [0.74-1.30],0.8968076971315616
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter II Neoplasms,Melanocytic naevi of trunk,19481,67,0.96 [0.62-1.49],0.8640407069893601
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter II Neoplasms,Melanoma in situ,13980,98,1.20 [0.91-1.58],0.1990974935743785
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter II Neoplasms,"Non-follicular lymphoma, hilmo, excluding all cancers",14036,102,1.03 [0.74-1.43],0.8745786168607268
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",14103,169,1.01 [0.78-1.31],0.9496493094334288
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",14223,289,1.09 [0.89-1.33],0.4131160334303431
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",14042,108,1.10 [0.82-1.48],0.5289649466244101
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter II Neoplasms,Other benign neoplasms of skin,19360,145,1.25 [1.02-1.54],0.0304724549113406
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",15161,1227,0.96 [0.86-1.06],0.3839133057772427
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",15226,1292,0.96 [0.87-1.06],0.4001223019188656
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,19248,309,1.06 [0.88-1.27],0.5663098806524096
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Anaemia in chronic diseases classified elsewhere,17622,106,0.70 [0.44-1.09],0.1156672980630943
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of spleen,18997,58,1.13 [0.77-1.68],0.5291574859062833
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,18893,2836,1.01 [0.95-1.08],0.753399517674697
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Folate deficiency anaemia,18123,60,1.02 [0.65-1.60],0.9306668987058172
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Idiopathic thrombocytopenic purpura,19126,54,0.79 [0.45-1.41],0.4269430871858872
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,19102,1586,0.97 [0.89-1.06],0.5277287797945971
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,19100,1584,0.97 [0.89-1.06],0.5386423834273804
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified aplastic anaemias,17612,96,0.89 [0.60-1.33],0.580963100023775
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,19206,1143,1.00 [0.90-1.11],0.9862020893420814
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other coagulation defects,19173,101,0.84 [0.56-1.25],0.3850980141105171
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other diseases of blood and blood-forming organs,18996,57,1.23 [0.87-1.76],0.245545371912607
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other disorders of white blood cells,19010,71,0.75 [0.45-1.27],0.2835452959508503
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Purpura and other haemorrhagic conditions,19350,278,1.06 [0.87-1.28],0.5831548479491333
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Sarcoidosis,19400,31,1.54 [1.15-2.07],0.0039855522077256
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,"Thrombocytopenia, unspecified",19301,229,1.09 [0.89-1.34],0.4041769659272538
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Vitamin B12 deficiency anaemia,18170,107,0.92 [0.64-1.33],0.6691804350170103
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter IV Endocrine, nutritional and metabolic diseases",Acidosis,13190,328,1.03 [0.85-1.24],0.7850447933901843
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter IV Endocrine, nutritional and metabolic diseases",Acute alcohol intoxication,18256,89,0.71 [0.41-1.22],0.2109926200138653
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter IV Endocrine, nutritional and metabolic diseases",Alcohol dependence,18257,90,0.59 [0.34-1.01],0.0526376684834331
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter IV Endocrine, nutritional and metabolic diseases",Alkalosis,12923,61,0.94 [0.59-1.50],0.8080550660306343
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter IV Endocrine, nutritional and metabolic diseases",Bipolar affective disorders,18148,43,0.81 [0.43-1.54],0.5193235623220032
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter IV Endocrine, nutritional and metabolic diseases",Deficiency of other B group vitamins,17545,259,1.06 [0.86-1.30],0.5925273224791652
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter IV Endocrine, nutritional and metabolic diseases","Delirium, not induced by alcohol and other psychoactive substances",18871,752,0.85 [0.74-0.99],0.03778088085278
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in Alzheimer disease,18526,407,0.89 [0.73-1.08],0.2292861641925258
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in other diseases classified elsewhere,18264,145,0.94 [0.69-1.28],0.7108535662306763
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter IV Endocrine, nutritional and metabolic diseases",Depression,19281,1176,1.03 [0.93-1.13],0.6122221552696976
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter IV Endocrine, nutritional and metabolic diseases",Depression or dysthymia,16505,1146,1.03 [0.93-1.13],0.6012559205035907
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of lipoprotein metabolism, unspecified",12931,69,1.10 [0.75-1.59],0.6329539167632876
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of thyroid, unspecified",17626,86,1.32 [1.03-1.69],0.0273854441876988
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of calcium metabolism,13153,291,0.97 [0.78-1.20],0.7606684597974012
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of iron metabolism,12910,48,0.89 [0.51-1.55],0.6727456762119489
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,16673,3811,0.99 [0.93-1.04],0.6565845831413857
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of magnesium metabolism,13088,226,0.99 [0.78-1.25],0.9232172183700332
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,13443,581,1.00 [0.86-1.15],0.950474817911646
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,19458,299,1.08 [0.90-1.30],0.401862343790033
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of parathyroid gland,19276,117,1.23 [0.96-1.57],0.108089861650111
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of phosphorus metabolism and phosphatases,12987,125,1.18 [0.92-1.50],0.1887353742391008
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter IV Endocrine, nutritional and metabolic diseases","Disorders of plasma-protein metabolism, not elsewhere classified",12928,66,1.26 [0.94-1.70],0.1247689811539614
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,18970,1430,1.07 [0.99-1.17],0.0990913955990568
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter IV Endocrine, nutritional and metabolic diseases",Fluid overload,13161,299,1.14 [0.96-1.36],0.1397797320950177
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter IV Endocrine, nutritional and metabolic diseases",Hyperkalaemia,13178,316,1.15 [0.98-1.36],0.0833574360866795
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",13572,710,1.06 [0.94-1.20],0.3495735019040009
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,12986,124,1.07 [0.80-1.43],0.6355340154652936
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,19270,111,1.22 [0.94-1.58],0.1304158422899451
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter IV Endocrine, nutritional and metabolic diseases",Hypo-osmolality and hyponatraemia,13595,733,1.03 [0.91-1.17],0.6309900199463926
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter IV Endocrine, nutritional and metabolic diseases",Hypokalaemia,13399,537,0.99 [0.85-1.16],0.9294227671804286
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter IV Endocrine, nutritional and metabolic diseases",Iron deficiency,17343,57,1.27 [0.91-1.77],0.1547335775791596
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,18203,5341,0.99 [0.94-1.04],0.6764016751732768
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic multinodular goitre,17589,49,1.00 [0.61-1.63],0.986624656441648
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic single thyroid nodule,17584,44,1.06 [0.66-1.71],0.8001404079101113
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,19360,1547,0.93 [0.84-1.02],0.1416921200092122
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",19359,1546,0.93 [0.85-1.03],0.1461021979337932
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter IV Endocrine, nutritional and metabolic diseases",Other and/or unspecified nontoxic goitre,17593,53,0.40 [0.19-0.88],0.0216270501375379
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter IV Endocrine, nutritional and metabolic diseases",Other anxiety disorders,19208,956,1.12 [1.02-1.24],0.0188992749501851
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",14670,1808,1.02 [0.95-1.11],0.5564672727262783
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter IV Endocrine, nutritional and metabolic diseases",Other disorders of glucose regulation and pancreatic internal secretion,19494,244,1.09 [0.88-1.34],0.4395623506329896
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,18213,94,0.69 [0.43-1.12],0.138405294343918
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter IV Endocrine, nutritional and metabolic diseases",Panic disorder,18352,100,0.78 [0.50-1.19],0.2492838729046555
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter IV Endocrine, nutritional and metabolic diseases",Phobic anxiety disorders,18394,142,0.81 [0.57-1.15],0.2406625781374869
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",13024,162,1.21 [0.99-1.48],0.0585388862333053
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,17187,155,1.13 [0.88-1.44],0.3411889491881397
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,2071,82,1.25 [0.85-1.84],0.2467302999529679
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,2206,248,1.09 [0.87-1.38],0.4504666618538828
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,17100,68,1.33 [1.00-1.77],0.0517993400944035
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,2037,49,1.41 [0.89-2.24],0.1416831191740595
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,18824,1792,0.94 [0.86-1.02],0.1536779482101783
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter IV Endocrine, nutritional and metabolic diseases",Unspecified dementia,18621,502,0.92 [0.78-1.10],0.367088533077651
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter IV Endocrine, nutritional and metabolic diseases",Vitamin D deficiency,17653,367,0.82 [0.66-1.01],0.0673177170261284
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,13740,878,1.04 [0.92-1.16],0.5466692868792533
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",19396,263,1.07 [0.88-1.31],0.4754756776976331
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,Abdominal aortic aneurysm (AAA),18274,223,0.92 [0.70-1.20],0.5289414720155842
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,Angina pectoris,16912,1275,1.10 [1.01-1.20],0.0349333686295689
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,Aortic aneurysm,18359,308,0.89 [0.71-1.12],0.3148370789334301
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,Arterial embolism and thrombosis of lower extremity artery,18117,66,1.18 [0.81-1.72],0.3778242593681921
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,"Atherosclerosis, excluding cerebral and coronary sclerosis",18283,232,1.07 [0.86-1.33],0.5462183880561369
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,9970,2338,0.99 [0.92-1.07],0.8446651903636601
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,AV-block,14957,543,0.98 [0.84-1.14],0.7548987370546041
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",19435,457,1.01 [0.86-1.19],0.913525646898012
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,Cardiac arrest,7853,221,0.94 [0.73-1.22],0.6555808165082847
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,Cardiomyopathy,14590,176,0.95 [0.71-1.25],0.6944977705593361
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,"Cardiomyopathy, other and unspecified",14503,89,0.76 [0.47-1.21],0.2435210295429943
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,Cerebral atherosclerosis,19501,62,1.15 [0.78-1.69],0.4679199895123156
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,Conduction disorders,15663,1249,1.00 [0.91-1.11],0.982880201636912
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,17908,2293,0.97 [0.90-1.05],0.5027277171805387
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,Death due to cardiac causes,15799,7491,0.98 [0.94-1.02],0.3784215775017922
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,DVT of lower extremities,18208,287,1.03 [0.85-1.25],0.7595856420209378
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,Endocarditis,14491,77,0.74 [0.45-1.22],0.2378668748852661
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,"Heart failure, strict",19260,1347,0.97 [0.88-1.07],0.5469699679266953
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,Hypertension,16820,6634,1.01 [0.97-1.05],0.6529347840387566
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,"Hypertension, essential",16825,6639,1.01 [0.97-1.05],0.631582559715187
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,"Hypertension, portal",19363,81,1.35 [1.05-1.74],0.0198794414328972
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",10420,234,0.94 [0.73-1.21],0.6336063257473988
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,10308,122,0.87 [0.60-1.26],0.4725335788592936
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,Hypotension,19358,1293,0.90 [0.81-1.00],0.052457942096002
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,Intracerebral haemorrhage,18450,123,0.96 [0.69-1.33],0.7882267509411038
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",18048,2411,0.98 [0.92-1.06],0.6674592529114294
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",19095,661,1.01 [0.88-1.16],0.8808794268584852
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,Left bundle-branch block,14826,412,1.00 [0.84-1.19],0.9859013815508229
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,Major coronary heart disease event,18951,875,0.96 [0.85-1.09],0.5033334089359496
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",16388,751,0.97 [0.85-1.10],0.6233621520531731
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",19393,162,0.99 [0.75-1.32],0.9629639244263666
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,"Myocardial infarction, without ST-elevation",19467,333,1.11 [0.94-1.32],0.229128867833848
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,Oesophageal varices,17979,58,1.14 [0.76-1.70],0.534179484825613
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,Other aneurysm,18136,85,0.99 [0.67-1.45],0.9550861149701868
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,Other arrhythmias,14901,487,0.87 [0.72-1.04],0.1146362444114422
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,Other arterial embolism and thrombosis,18158,107,1.09 [0.79-1.50],0.6174163994286392
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,18319,268,1.10 [0.91-1.33],0.3326362788989256
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,Other diseases of pericardium,14602,188,0.83 [0.62-1.13],0.2357602144464228
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,Other disorders of veins,18005,84,0.95 [0.63-1.43],0.8090853096771177
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,Other embolism and thrombosis,17958,37,0.96 [0.52-1.75],0.8872001461324192
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,Other intracranial haemorrhages,17818,72,0.87 [0.55-1.40],0.5724781864309636
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,Other noninfective disorders of lymphatic vessels and lymph nodes,18060,139,0.87 [0.62-1.23],0.4387945051961406
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,15588,1174,1.01 [0.91-1.12],0.8872570564511001
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,Other other unspecified disorders of the circulatory system,18116,51,1.31 [0.94-1.83],0.1092884758070757
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,18647,596,0.97 [0.83-1.12],0.6531044087120697
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,18865,451,1.00 [0.85-1.18],0.9778961492497684
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,"Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere",18543,797,1.02 [0.90-1.15],0.7575975440542183
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,7979,347,1.02 [0.84-1.22],0.8717505003880789
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,Peripheral artery disease,18503,482,0.96 [0.81-1.14],0.6649722535559031
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),18276,355,1.01 [0.84-1.21],0.9130703859830146
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,Pulmonary embolism,18905,491,0.97 [0.82-1.14],0.6799422768553358
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,19420,787,0.95 [0.84-1.09],0.4831472524733011
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,Right bundle-branch block,14832,418,1.01 [0.86-1.20],0.863263215788653
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,Secondary right heart disease,18861,447,1.00 [0.85-1.19],0.9543330561035708
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,Sequelae of cerebrovascular disease,17961,215,0.92 [0.71-1.20],0.5564367470894303
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",19079,752,1.00 [0.87-1.13],0.9466009125586392
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,"Stroke, including SAH",19068,783,1.00 [0.88-1.13],0.9937704836419384
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,Subarachnoid haemorrhage,18425,49,0.96 [0.57-1.61],0.878969840335146
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,Thoracic aortic aneurysm,18132,81,0.74 [0.45-1.21],0.2232837126048784
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,Transient ischemic attack,18687,253,1.08 [0.89-1.32],0.4238656032117472
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,Unstable angina pectoris,18349,273,0.94 [0.75-1.18],0.5854519257684385
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,Varicose veins,18344,423,0.84 [0.69-1.02],0.0783395849607452
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,Vascular diseases of the intestine,18066,97,0.96 [0.67-1.39],0.8449052569594031
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,Venous thromboembolism,19272,779,0.98 [0.87-1.12],0.796637416775055
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",19437,279,1.02 [0.82-1.26],0.8727166978004122
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",16751,1163,1.06 [0.96-1.16],0.2392360043871603
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter V Mental and behavioural disorders,Any mental disorder,19070,3482,1.00 [0.95-1.07],0.8965706501408062
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",19412,330,0.97 [0.79-1.18],0.7412305274613298
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",16784,1196,1.02 [0.92-1.12],0.748980410904888
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",15649,61,0.69 [0.38-1.25],0.2243414908841266
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter V Mental and behavioural disorders,Smoking dependency,19083,972,1.02 [0.90-1.16],0.7166258605913424
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",16791,1203,1.00 [0.90-1.11],0.9794043255152308
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter V Mental and behavioural disorders,Vascular dementia,18799,196,0.99 [0.77-1.28],0.9590093185326496
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter VI Diseases of the nervous system,Alzheimer disease,19502,498,0.85 [0.70-1.02],0.0728662215100867
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter VI Diseases of the nervous system,"Alzheimer√ïs disease (Atypical or mixed), excluding more controls",12164,96,0.74 [0.47-1.17],0.1976524209380198
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter VI Diseases of the nervous system,Bell's palsy,17985,71,0.75 [0.45-1.26],0.2744441031243446
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,18332,418,0.93 [0.77-1.11],0.4300764148293812
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter VI Diseases of the nervous system,Cerebral cysts,19143,205,1.03 [0.82-1.31],0.7774501148864312
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,19441,323,0.96 [0.78-1.18],0.6726856976560126
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter VI Diseases of the nervous system,Circumscribed brain atrophy,18818,71,0.92 [0.59-1.44],0.7179447201930713
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter VI Diseases of the nervous system,Diseases of the myoneural junction and muscle,19487,59,1.09 [0.72-1.65],0.6774123144592077
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter VI Diseases of the nervous system,"Disorders of brain, other and unspecified",19008,70,1.10 [0.76-1.59],0.626580336866938
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter VI Diseases of the nervous system,Epilepsy,18279,240,1.03 [0.83-1.27],0.8177809540777392
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,19121,1082,0.99 [0.89-1.10],0.8541462408655061
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter VI Diseases of the nervous system,Extrapyramidal and movement disorders,19453,528,1.00 [0.86-1.16],0.9861228429486204
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter VI Diseases of the nervous system,Falls/tendency to fall,18949,2805,1.00 [0.93-1.06],0.9001712188026023
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter VI Diseases of the nervous system,Generalized epilepsy,19202,44,1.04 [0.62-1.72],0.8898620691489141
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter VI Diseases of the nervous system,Hemiplegia,19382,264,0.99 [0.79-1.23],0.9008178850833234
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter VI Diseases of the nervous system,Hydrocephalus,18996,58,0.61 [0.32-1.16],0.1290409212603006
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter VI Diseases of the nervous system,Inflammatory diseases of the central nervous system,19490,57,0.73 [0.41-1.31],0.2993089246025368
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter VI Diseases of the nervous system,Lesion of plantar nerve,17974,60,1.05 [0.70-1.58],0.8129753110083513
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter VI Diseases of the nervous system,Lesion of ulnar nerve,17976,62,0.97 [0.61-1.55],0.9058003355546992
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter VI Diseases of the nervous system,Memory loss,18585,128,1.07 [0.81-1.42],0.6264333805156563
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter VI Diseases of the nervous system,Migraine,18271,232,0.90 [0.71-1.15],0.4149940018661259
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",19460,214,0.83 [0.63-1.09],0.1734020245625085
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter VI Diseases of the nervous system,Motor neuron disease,12250,161,1.03 [0.79-1.33],0.8303213009475267
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,19395,47,1.07 [0.68-1.70],0.7575824172778434
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",18925,1011,0.95 [0.85-1.07],0.4091312634368126
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter VI Diseases of the nervous system,Neurological diseases,18276,3453,0.98 [0.92-1.04],0.4439225401565407
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter VI Diseases of the nervous system,Other and unspecified degenerative diseases of nervous system,18983,236,0.99 [0.78-1.25],0.9217637611528772
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",18244,330,0.91 [0.74-1.12],0.3764482302452939
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter VI Diseases of the nervous system,"Other and unspecified polyneuropathies, also in other diseases",19439,282,0.94 [0.75-1.17],0.575396337534748
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,14798,791,0.93 [0.82-1.07],0.3215021008952496
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter VI Diseases of the nervous system,Other diseases of spinal cord,19004,66,0.92 [0.58-1.47],0.7323094991527106
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter VI Diseases of the nervous system,Other disorders of nervous system,19070,132,0.87 [0.62-1.24],0.4513189932247086
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter VI Diseases of the nervous system,Other extrapyramidal and movement disorders in other diseases,19103,178,0.98 [0.75-1.27],0.8763137496306839
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter VI Diseases of the nervous system,Other facial nerve disorders,17992,78,0.79 [0.49-1.28],0.3434782138646606
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter VI Diseases of the nervous system,Other headache syndromes,18083,44,0.88 [0.48-1.58],0.6595071982953715
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter VI Diseases of the nervous system,Other neurological diseases,19410,472,0.95 [0.81-1.13],0.5853500873534137
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter VI Diseases of the nervous system,Other sleep disorders,18449,410,1.04 [0.88-1.23],0.6598204627908713
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter VI Diseases of the nervous system,Parkinson's disease,19471,333,1.07 [0.90-1.27],0.4632628840952933
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter VI Diseases of the nervous system,Postviral fatigue syndrome,18975,37,0.77 [0.38-1.54],0.4551447196107618
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter VI Diseases of the nervous system,Restless leg syndrome,19501,78,1.07 [0.75-1.54],0.709951950985246
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter VI Diseases of the nervous system,Sleep apnoea,19317,352,0.98 [0.81-1.19],0.822799672490876
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter VI Diseases of the nervous system,Small fibre neuropathy,19207,50,0.92 [0.54-1.56],0.7458573988775608
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,19490,181,1.08 [0.86-1.36],0.5141793351058352
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter VI Diseases of the nervous system,Trigeminal neuralgia,17975,61,0.70 [0.40-1.26],0.2355948759899141
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter VI Diseases of the nervous system,Unspecific neurodegenerative disorder,19502,503,0.85 [0.71-1.02],0.0888643555539964
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter VI Diseases of the nervous system,Vascular dementia (undefined),18744,190,1.00 [0.78-1.30],0.9759730549892568
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Amblyopia ex anopsia,18973,127,1.15 [0.88-1.48],0.3056532765385237
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Astigmatism,19138,477,1.09 [0.95-1.26],0.2111123984482807
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,19301,219,1.05 [0.83-1.32],0.6930917756329044
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Blepharochalasis,18477,59,0.85 [0.50-1.44],0.5453282453585115
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,18451,33,0.98 [0.53-1.81],0.9528600281037464
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Conjunctivitis (acute, non atopic)",19399,63,1.02 [0.66-1.58],0.9255165859916572
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Corneal degeneration,19243,192,0.96 [0.74-1.24],0.7649153071217735
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",2041,52,1.43 [0.92-2.22],0.1166690665480578
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic neuropathy,2512,93,1.23 [0.87-1.75],0.2477627923660655
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diplopia,18935,89,0.91 [0.61-1.36],0.6529991234555759
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,19270,1190,1.01 [0.92-1.12],0.8008802137554187
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",19146,728,1.06 [0.94-1.20],0.3124312304640266
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,18671,253,1.02 [0.83-1.27],0.8280348669523726
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",19450,789,1.07 [0.96-1.20],0.2212642826380484
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of optic nerve and visual pathways,19496,69,0.97 [0.63-1.48],0.8767276780724788
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of refraction and accommodation,19398,737,1.08 [0.97-1.21],0.1671763356359673
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of sclera, cornea, iris and ciliary body",19467,416,1.04 [0.88-1.22],0.6640321748233833
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,19401,186,1.01 [0.79-1.30],0.9368871423679742
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ectropion of eyelid,18501,83,1.14 [0.82-1.59],0.4356611610714043
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Entropion and trichiasis of eyelid,18504,86,0.98 [0.66-1.46],0.929266230466011
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Epiphora,18484,66,0.95 [0.61-1.49],0.834381791862318
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,19392,845,0.99 [0.88-1.12],0.8727279085514185
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma suspect,18771,224,1.00 [0.80-1.26],0.9895970684701926
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Hypermetropia,18717,56,0.80 [0.46-1.40],0.4441476666029131
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Iridocyclitis,19155,104,1.09 [0.81-1.48],0.564040310908011
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Keratitis,19374,323,0.99 [0.82-1.21],0.952912997176251
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Myopia,18844,183,1.19 [0.97-1.45],0.091509778831431
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified disorders of vitreous body,19330,115,0.92 [0.65-1.30],0.6422169243608067
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,19101,554,0.96 [0.82-1.11],0.5691192238041081
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,18982,136,1.08 [0.83-1.41],0.5682669942646996
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,17468,2709,0.99 [0.92-1.05],0.662161450451894
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of cornea,19340,289,1.01 [0.83-1.24],0.9063756264562514
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eye and adnexa,19487,158,1.11 [0.87-1.42],0.3927273139994208
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,18865,447,1.04 [0.89-1.22],0.6066191833075861
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of iris and ciliary body,19127,76,0.98 [0.65-1.48],0.9330659271256012
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of optic [2nd] nerve and visual pathways,19489,62,1.10 [0.75-1.63],0.6297577651640937
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other inflammation of eyelid,18526,108,1.17 [0.89-1.54],0.2492928725679083
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,18567,149,1.10 [0.86-1.42],0.4390130333139305
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified retinal disorders,18215,135,0.91 [0.66-1.26],0.5763917845780204
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other strabismus,18707,46,0.98 [0.59-1.64],0.941582767925283
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Other, unspecified and serous retinal detachments",18144,64,0.82 [0.49-1.36],0.4416197635713701
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Primary angle-closure glaucoma,18645,98,1.03 [0.75-1.44],0.8406446239682777
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Primary open-angle glaucoma, strict",18788,241,0.79 [0.60-1.04],0.0875565683923703
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ptosis of eyelid,18544,126,0.90 [0.63-1.27],0.5327909929240582
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal detachment with retinal break,18158,78,0.77 [0.48-1.25],0.2908795750294055
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal vascular occlusion,18184,104,1.06 [0.78-1.45],0.6949811518055964
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,17013,2254,1.02 [0.95-1.09],0.6514094165037476
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Stenosis and insufficiency of lacrimal passages,18499,81,0.98 [0.67-1.46],0.9348736944096652
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,19265,419,1.09 [0.94-1.27],0.2629329580734996
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,18910,64,1.26 [0.90-1.75],0.1735072567206355
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),19004,158,0.83 [0.60-1.15],0.2604730480136119
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter VIII Diseases of the ear and mastoid process,Benign paroxysmal vertigo,19308,91,0.83 [0.54-1.27],0.3908564946005944
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter VIII Diseases of the ear and mastoid process,Diseases of external ear,19467,116,1.31 [1.05-1.63],0.0178017221219965
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter VIII Diseases of the ear and mastoid process,Diseases of middle ear and mastoid,19393,94,0.97 [0.68-1.41],0.8922730737596095
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter VIII Diseases of the ear and mastoid process,Labyrinthitis,19273,56,1.10 [0.73-1.66],0.6471355366603482
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter VIII Diseases of the ear and mastoid process,M¬éni¬ère disease,19274,57,1.34 [0.99-1.80],0.0574396413885961
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter VIII Diseases of the ear and mastoid process,Other disorders of ear,19410,1002,1.05 [0.95-1.17],0.3357740603587796
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter VIII Diseases of the ear and mastoid process,Other specified/unspecified hearing loss,19167,759,1.02 [0.90-1.16],0.7119832647863846
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter VIII Diseases of the ear and mastoid process,Sensorineural hearing loss,18531,123,1.03 [0.76-1.41],0.8384973329135917
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter VIII Diseases of the ear and mastoid process,Tinnitus,18484,76,1.24 [0.92-1.68],0.1541286951202526
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter X Diseases of the respiratory system,Acute pharyngitis,19336,51,1.12 [0.73-1.70],0.6038173950634
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter X Diseases of the respiratory system,Acute upper respiratory infections,19436,151,1.00 [0.76-1.32],0.997327137338888
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter X Diseases of the respiratory system,Acute upper respiratory infections of multiple and unspecified sites,19335,50,1.05 [0.67-1.67],0.8192784179061738
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter X Diseases of the respiratory system,All influenza,17336,120,1.11 [0.83-1.47],0.4810630198871717
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter X Diseases of the respiratory system,All influenza (not pneumonia),17334,118,1.12 [0.84-1.48],0.4469980340914046
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter X Diseases of the respiratory system,Allergic asthma (mode),12112,83,1.02 [0.70-1.48],0.9125459295125148
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter X Diseases of the respiratory system,Allergic rhinitis,19422,203,1.14 [0.93-1.39],0.2059306151307008
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",13182,1468,1.01 [0.92-1.10],0.8771409894986011
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",13481,1452,1.00 [0.91-1.10],0.9818284615229153
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter X Diseases of the respiratory system,Bacterial pneumonia (organism specified),19073,146,1.08 [0.83-1.41],0.5807697875492844
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter X Diseases of the respiratory system,"Bacterial pneumonia, not elsewhere classified",17301,85,0.81 [0.51-1.30],0.3820944161815888
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter X Diseases of the respiratory system,Bronchiectasis,16329,424,1.17 [1.02-1.34],0.0298797316909642
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter X Diseases of the respiratory system,"Bronchitis, not specified as acute or chronic",15964,59,0.95 [0.59-1.52],0.8270052351632959
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,18560,2655,1.03 [0.96-1.10],0.3706392107534928
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter X Diseases of the respiratory system,"Chronic rhinitis, nasopharyngitis and pharyngitis",18466,67,1.26 [0.93-1.71],0.1307769730109757
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter X Diseases of the respiratory system,Chronic sinusitis,18510,111,0.99 [0.71-1.37],0.9394403033314308
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",19257,1343,0.99 [0.89-1.09],0.7951664007334068
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter X Diseases of the respiratory system,Deviated nasal septum,18467,68,0.61 [0.34-1.11],0.1074472237569562
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter X Diseases of the respiratory system,Diseases of the respiratory system,17696,5071,1.03 [0.98-1.08],0.2929233629306723
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",18690,291,0.93 [0.74-1.16],0.5038683254857075
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter X Diseases of the respiratory system,Early onset COPD,18014,100,0.98 [0.68-1.41],0.9250954079785496
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter X Diseases of the respiratory system,Emphysema,16269,364,1.06 [0.89-1.27],0.4922049486821455
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,18391,391,1.26 [1.10-1.44],0.0006292060691811
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter X Diseases of the respiratory system,Influenza and pneumonia,19282,2066,1.05 [0.98-1.13],0.1720916327101821
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter X Diseases of the respiratory system,Interstitial lung disease,18426,426,1.22 [1.07-1.40],0.0030607264186442
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter X Diseases of the respiratory system,Later onset COPD,19050,1243,0.99 [0.89-1.10],0.8177171245257489
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter X Diseases of the respiratory system,Lung diseases due to external agents,19488,380,0.87 [0.71-1.07],0.1924235706117362
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter X Diseases of the respiratory system,Nasal polyp,18479,80,0.86 [0.55-1.35],0.5070398142343929
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,19262,1040,0.95 [0.85-1.06],0.3656205790075491
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter X Diseases of the respiratory system,Other diseases of pleura,19261,2221,1.03 [0.96-1.11],0.3835180303065004
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,19039,640,1.02 [0.90-1.17],0.7150329536463449
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter X Diseases of the respiratory system,Other pleural conditions,17091,51,0.87 [0.49-1.53],0.6204862399439913
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,19392,499,1.20 [1.06-1.36],0.0048185463798849
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,19392,1433,1.03 [0.94-1.12],0.5753927833661052
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter X Diseases of the respiratory system,Pleural effusion,18139,1099,0.99 [0.89-1.10],0.8579466764619843
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter X Diseases of the respiratory system,Pleural plaque,17254,214,1.15 [0.93-1.43],0.1885127331915013
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",19049,1833,1.03 [0.95-1.12],0.4369652935802963
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter X Diseases of the respiratory system,Pneumonitis due to solids and liquids,19393,285,0.79 [0.61-1.02],0.0693868461616571
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter X Diseases of the respiratory system,Pneumothorax,17187,147,1.12 [0.86-1.44],0.4027653935109511
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter X Diseases of the respiratory system,Pollen allergy,19493,171,1.17 [0.95-1.44],0.1413639127022648
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter X Diseases of the respiratory system,Pulmonary oedema,18966,73,1.03 [0.68-1.55],0.8993064230927191
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter X Diseases of the respiratory system,Respiratory insufficiency,12089,60,0.51 [0.26-1.01],0.0530940884606575
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,19248,1026,0.95 [0.85-1.07],0.3966244062468822
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter X Diseases of the respiratory system,Vasomotor and allergic rhinitis,18603,204,1.13 [0.92-1.38],0.2352171010719077
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter X Diseases of the respiratory system,Viral pneumonia,17456,240,1.11 [0.90-1.36],0.3397993906089983
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter X Diseases of the respiratory system,"Viral pneumonia (unknown virus, not influenza)",19087,192,1.07 [0.84-1.35],0.585538944242961
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter X Diseases of the respiratory system,Vocal cord dysfunction,6300,103,0.94 [0.64-1.37],0.7405123267354694
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,12476,49,1.09 [0.69-1.72],0.7185635410586018
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Acute appendicitis,19401,109,1.05 [0.77-1.44],0.739329284012404
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Acute gastritis,13632,81,1.05 [0.72-1.51],0.812335584843244
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Acute pancreatitis,17824,161,0.77 [0.55-1.09],0.1355002908381734
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Acute peritonitis,19097,89,0.92 [0.62-1.38],0.6959524207497705
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Alcoholic liver disease,18685,49,1.28 [0.89-1.83],0.1765809132106078
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Barrett oesophagus,13967,416,0.93 [0.78-1.12],0.4485981511660373
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC)",17783,120,1.02 [0.75-1.40],0.888235777291167
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC), with reimbursement 202",19162,120,1.02 [0.75-1.40],0.8800401412371094
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Cholecystitis,17842,179,0.98 [0.75-1.29],0.908912920945862
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Cholelithiasis,18535,872,0.95 [0.84-1.08],0.4478615366270431
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Chronic gastritis,13836,285,0.93 [0.75-1.15],0.5022715942692813
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Chronic pancreatitis,17707,44,0.99 [0.58-1.70],0.9736083397856962
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,"Cirrhosis of liver, NAS",19390,108,1.19 [0.91-1.56],0.2047496981663249
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Coeliac disease,18062,103,1.43 [1.18-1.73],0.0002294433753149
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Collagenous colitis,18038,88,0.99 [0.69-1.42],0.9461685867926866
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,19405,143,0.98 [0.73-1.32],0.909973773794925
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Constipation,19260,1732,1.01 [0.93-1.10],0.7351669348650598
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Crohn disease,18015,65,1.10 [0.75-1.62],0.610550546106323
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",19212,49,1.19 [0.80-1.77],0.3998363766574586
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Crohn's disease NAS,18009,59,0.89 [0.54-1.48],0.6647585085217007
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Dental caries,18983,159,1.11 [0.87-1.41],0.4148557221098798
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Diaphragmatic hernia,16907,2142,0.99 [0.92-1.07],0.8036605634861029
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Diseases of appendix,19427,135,1.04 [0.78-1.38],0.7941793624043831
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Diseases of liver,19408,772,1.03 [0.92-1.17],0.5824947294051463
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",17383,3832,0.98 [0.92-1.04],0.4570861627325793
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",19217,393,0.99 [0.83-1.18],0.9005520371324287
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Diseases of peritoneum,19430,422,1.04 [0.89-1.22],0.6132084650342317
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,18900,76,0.95 [0.63-1.44],0.805197627860177
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Diseases of salivary glands,18797,43,0.79 [0.42-1.52],0.4856367988356648
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Diseases of the digestive system,19230,1271,1.04 [0.95-1.14],0.397183874827727
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Diseases of tongue,18810,80,1.09 [0.77-1.54],0.6300286026232493
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",18926,1263,0.96 [0.86-1.06],0.4110785163262676
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Diverticular disease of intestine,15608,3181,1.02 [0.96-1.09],0.4444274586966664
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Duodenal ulcer,13749,198,0.77 [0.56-1.05],0.0949439987481772
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",19415,160,0.76 [0.54-1.08],0.1288364354962405
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Embedded and impacted teeth,19474,17,0.70 [0.23-2.08],0.5153800197623424
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Fibrosis and cirrhosis of liver,18763,127,1.16 [0.89-1.50],0.2674200154707503
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,12522,95,0.91 [0.62-1.35],0.6487335676004824
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Functional dyspepsia,14029,478,0.98 [0.83-1.14],0.7720768798473187
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Gastric ulcer,13912,361,0.97 [0.81-1.17],0.7722129538063648
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,15767,2216,0.96 [0.90-1.04],0.3508227442391809
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,14091,540,0.87 [0.73-1.03],0.1142668570563759
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Gastrointestinal diseases,14172,6913,1.00 [0.96-1.05],0.83980072672633
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,GI-bleeding,19003,1044,0.99 [0.88-1.10],0.8014614568582175
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Gingivitis and periodontal diseases,18868,44,1.00 [0.60-1.68],0.9855992222975198
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Haemorrhoids and perianal venous thrombosis,13264,998,1.00 [0.90-1.12],0.9294682615230228
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,"Hepatic failure, not elsewhere classified",18695,59,1.35 [1.00-1.83],0.0493155627772763
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Hernia,17787,3022,0.98 [0.92-1.05],0.5852221445822585
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Impacted teeth,19476,16,0.67 [0.21-2.12],0.4993722966853484
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Impaction of intestines,12490,63,0.99 [0.64-1.55],0.9819756061133182
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Inguinal hernia,15669,904,0.94 [0.83-1.06],0.2977199095580872
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,"Inguinal hernia, bilateral",14864,99,1.06 [0.77-1.48],0.7158980669721429
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Intestinal adhesions without obstruction,12523,96,0.94 [0.65-1.37],0.7535552803384749
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Intestinal malabsorption,18081,122,1.34 [1.10-1.63],0.0031017046004259
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Irritable bowel syndrome,12856,429,1.00 [0.85-1.18],0.9713688032300876
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Nonalcoholic fatty liver disease,19483,275,1.05 [0.85-1.28],0.6633013517007071
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,18606,656,1.08 [0.95-1.22],0.2446413571403705
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,18863,913,1.08 [0.98-1.20],0.1365858015035704
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Oesophageal obstruction,13733,182,0.92 [0.69-1.21],0.5406068895675067
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Oesophagitis,14138,587,0.98 [0.85-1.13],0.7978780000943517
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Oral lichen ruber planus,19452,113,0.98 [0.70-1.36],0.881580881205536
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Other and unspecified abdominal hernia,14835,70,1.04 [0.70-1.54],0.8375991328804941
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,13573,1146,1.05 [0.95-1.16],0.3092780219391658
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Other diseases of biliary tract,17956,293,0.98 [0.80-1.21],0.8673761906183879
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Other diseases of gallbladder,17787,124,1.20 [0.93-1.54],0.1543144538557952
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Other diseases of intestine,14056,1629,1.02 [0.93-1.11],0.7061287554855293
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Other diseases of intestines,17581,5154,1.00 [0.96-1.05],0.9021202821805177
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,18778,181,1.02 [0.79-1.31],0.8880465487062378
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Other diseases of liver,19269,633,1.04 [0.91-1.19],0.5884751355468811
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Other diseases of oesophagus,14187,636,0.93 [0.80-1.08],0.329804327496583
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Other diseases of pancreas,17834,171,0.99 [0.76-1.30],0.9563790363911372
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Other diseases of peritoneum,19369,361,1.06 [0.90-1.26],0.4720800209386214
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,14468,917,0.96 [0.85-1.08],0.4667948957523178
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Other diseases of the digestive system,19015,1056,0.99 [0.89-1.10],0.8170371340774031
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,18967,143,0.94 [0.69-1.28],0.6945990373858866
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Other functional intestinal disorders,14196,1769,1.01 [0.93-1.10],0.7961561116669085
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),15369,1818,0.97 [0.90-1.06],0.5161989926477788
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Other inflammatory liver diseases,18731,95,1.21 [0.91-1.60],0.183578940562446
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,18763,813,1.07 [0.95-1.19],0.2541041957577796
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",12786,359,0.92 [0.75-1.13],0.4160128151783544
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Palatinal maxillary canine,19471,20,0.78 [0.31-1.98],0.6020026166361665
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,12930,503,0.98 [0.84-1.15],0.8306290905094612
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",18095,136,1.04 [0.78-1.39],0.7697915175379837
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Recurring oral aphthae,19490,44,0.77 [0.40-1.47],0.428795773600653
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Stomatitis and related lesions,18816,83,0.85 [0.55-1.31],0.4581245424131328
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Toxic colitis,18019,69,1.08 [0.73-1.59],0.6975815191643439
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Ulcer of oesophagus,13840,289,0.87 [0.69-1.10],0.2416297912446865
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Ulcerative colitis,18085,135,1.19 [0.94-1.51],0.1378522666941153
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",18059,109,1.09 [0.81-1.47],0.5746036591555568
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Umbilical hernia,14980,215,0.90 [0.69-1.18],0.4392007796655627
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Vascular disorders of the intestines,12628,201,0.88 [0.67-1.17],0.3845281134770232
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Ventral hernia,14988,223,1.15 [0.94-1.40],0.1677431364166457
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Volvulus,12502,75,1.07 [0.74-1.55],0.7359798985461692
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XII Diseases of the skin and subcutaneous tissue,Actinic keratosis,19417,342,1.11 [0.94-1.30],0.2289875970003637
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XII Diseases of the skin and subcutaneous tissue,Arthropathic psoriasis,19202,61,1.07 [0.72-1.60],0.7247232973633715
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,17399,141,1.03 [0.78-1.36],0.826757586409473
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,18977,687,0.88 [0.76-1.02],0.0995657797560327
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",18410,120,1.18 [0.91-1.53],0.2051570814002853
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XII Diseases of the skin and subcutaneous tissue,Decubitus ulcer and pressure area,17749,491,1.03 [0.88-1.20],0.7429368142458707
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis,19211,256,0.89 [0.70-1.14],0.3532320470777648
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,19410,455,0.96 [0.81-1.14],0.6420658438931226
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis due to substances taken internally,18998,43,1.24 [0.85-1.83],0.2655920654113647
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,18149,3084,0.99 [0.92-1.05],0.6514967229543952
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,19132,365,1.01 [0.85-1.21],0.8694921804064764
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,19019,252,0.96 [0.77-1.21],0.7531830460089546
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,19183,893,0.96 [0.85-1.08],0.5014838559157933
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XII Diseases of the skin and subcutaneous tissue,"Lichen planus, including avohilmo",19486,49,1.02 [0.63-1.64],0.9488036576887162
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XII Diseases of the skin and subcutaneous tissue,Lupus erythematosus,17312,54,0.85 [0.49-1.47],0.5570163211924122
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,18819,52,1.00 [0.61-1.63],0.9890332831330808
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified dermatitis,19199,244,0.89 [0.69-1.14],0.3528724078786165
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,17759,501,0.91 [0.76-1.07],0.2553374817361781
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified epidermal thickening,17333,75,1.07 [0.73-1.57],0.7099313611669815
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified erythematous conditions,19429,69,0.97 [0.63-1.50],0.901190498740284
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified local infections of skin and subcutaneous tissue,18471,181,1.12 [0.89-1.40],0.3383856253963525
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,19332,191,1.04 [0.81-1.32],0.7698782824708794
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XII Diseases of the skin and subcutaneous tissue,Other contact dermatitis,19027,72,0.90 [0.57-1.43],0.6647213361306088
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of pigmentation,17317,59,1.46 [1.12-1.89],0.0043193912750329
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,18976,1718,0.99 [0.91-1.08],0.821124687711082
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",17797,539,0.87 [0.74-1.03],0.1157239994511484
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XII Diseases of the skin and subcutaneous tissue,Other epidermal thickening,17336,78,1.06 [0.73-1.55],0.7573120756335743
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,19428,287,1.04 [0.85-1.26],0.7184436637245148
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XII Diseases of the skin and subcutaneous tissue,Pruritus,19020,65,1.04 [0.69-1.57],0.8679088869083709
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,19378,237,1.04 [0.84-1.29],0.6902693667394885
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,19444,369,1.10 [0.94-1.29],0.2431593020592953
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,17366,108,1.13 [0.85-1.50],0.3986689588802217
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,17538,280,1.06 [0.88-1.29],0.5226249459843586
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,19433,358,1.11 [0.94-1.30],0.2098656204148289
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XII Diseases of the skin and subcutaneous tissue,"Ulcer of lower limb, not elsewhere classified",17521,263,0.91 [0.72-1.16],0.4588974397837554
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XII Diseases of the skin and subcutaneous tissue,Urticaria and erythema,19478,118,1.12 [0.84-1.47],0.4409224355073162
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Adhesive capsulitis of shoulder,16291,65,1.17 [0.83-1.65],0.3831845685243388
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,17215,5388,0.95 [0.91-1.00],0.0619025127663541
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,16021,4194,0.97 [0.92-1.02],0.2598385086505713
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Bursitis of shoulder,16271,45,1.23 [0.84-1.79],0.2862409714380863
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,16270,116,0.75 [0.49-1.13],0.1641169384232111
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,16304,150,1.09 [0.84-1.41],0.5079988552126102
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Chondropathies,19288,49,0.85 [0.48-1.50],0.5691216720825552
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Collapsed vertebra, not elsewhere classified",16275,121,0.99 [0.72-1.37],0.966408160708713
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,13070,1243,0.91 [0.82-1.01],0.0770187290388737
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",19322,207,0.90 [0.69-1.18],0.4436615404808146
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,16620,466,1.04 [0.90-1.22],0.5699813430357528
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,15824,6744,0.97 [0.93-1.01],0.1664188164563158
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,17413,103,0.75 [0.48-1.15],0.1846152618197747
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of muscles,16374,148,1.02 [0.77-1.35],0.8782495265108485
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,16654,428,0.92 [0.77-1.09],0.3375196739942779
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,18724,2570,1.02 [0.96-1.09],0.5268111288264066
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,16492,266,0.98 [0.79-1.22],0.8886817784407692
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibromyalgia,16350,124,0.82 [0.57-1.17],0.2748853110232358
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,16327,101,0.96 [0.68-1.35],0.8192337081239345
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Giant cell arteritis,18856,86,0.86 [0.56-1.32],0.481977377341007
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,13499,1672,0.95 [0.87-1.04],0.2277123949418091
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,12463,636,0.94 [0.81-1.09],0.4368775892300766
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",19420,630,0.96 [0.83-1.11],0.5856486624991739
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,11890,63,0.90 [0.56-1.43],0.6484792849295
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),12088,261,0.89 [0.71-1.12],0.3292597548105091
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,16443,217,1.02 [0.82-1.28],0.8392619370278953
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,12233,406,1.07 [0.92-1.25],0.3833683834410625
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Kyphosis,16219,65,0.93 [0.58-1.48],0.7489651655276937
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,16705,551,0.86 [0.72-1.02],0.0870105955850821
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,16405,251,0.86 [0.67-1.10],0.2357461274640692
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,12206,379,1.06 [0.90-1.25],0.4718840088268966
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Myalgia,16285,59,0.77 [0.44-1.35],0.3634909115546837
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Neuralgia and neuritis, unspecified",16273,47,1.06 [0.66-1.69],0.810963829210116
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteomyelitis,17375,65,1.07 [0.71-1.59],0.7572673747584255
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,19148,1838,1.03 [0.96-1.12],0.399655384181516
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,18609,1299,1.08 [0.99-1.18],0.0714677310521752
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",19362,456,1.06 [0.91-1.24],0.4217978425160559
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,14436,2609,0.99 [0.93-1.06],0.78937667549186
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other articular cartilage disorders,11867,40,0.59 [0.27-1.28],0.178595417394664
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other bursopathies,16310,84,1.07 [0.77-1.50],0.691389932549997
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other crystal arthropathies,11892,65,0.95 [0.60-1.50],0.8242253333233049
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),11941,114,0.99 [0.72-1.37],0.9709591903839244
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,17512,202,0.91 [0.70-1.19],0.4761654709463768
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone density and structure,17714,404,0.89 [0.74-1.08],0.2270021335365807
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of the musculoskeletal system and connective tissue,19485,88,0.95 [0.64-1.39],0.7823680182976329
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",17771,1617,1.01 [0.92-1.10],0.8967657650204972
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,16285,59,0.65 [0.36-1.20],0.1691622507289727
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),11954,127,0.78 [0.54-1.13],0.1939419950130337
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,16803,649,1.00 [0.87-1.15],0.9982306615666235
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,13659,1832,0.95 [0.87-1.03],0.2427714521251577
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other necrotizing vasculopathies,18876,106,0.96 [0.68-1.36],0.825297423142044
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other psoriatic arthropathies,19495,58,1.07 [0.71-1.62],0.7552188696494273
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,16293,67,0.68 [0.39-1.21],0.1920256419042032
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",17327,1101,0.96 [0.86-1.07],0.4565396896326513
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified disorders of muscle,16315,89,1.03 [0.73-1.47],0.8615857387982009
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,13563,1736,0.91 [0.84-1.00],0.0533785939324378
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,17413,103,0.93 [0.65-1.33],0.6950916679193171
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies,16252,26,1.19 [0.72-1.97],0.4908736834185443
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified inflammatory spondylopathies,16316,162,1.00 [0.76-1.32],0.9840923486466308
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,16777,551,0.97 [0.84-1.13],0.7376108700507189
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,19183,413,0.74 [0.59-0.91],0.0054483849065004
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,16684,530,1.00 [0.86-1.17],0.9531189952760084
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,19374,452,1.04 [0.89-1.21],0.6244351099328798
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified seropositive rheumatoid arthritis,19481,58,0.91 [0.55-1.49],0.6977927099139407
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,16365,139,0.83 [0.59-1.17],0.2938707854007243
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,15214,718,1.00 [0.88-1.13],0.9647800396764996
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,16747,521,0.93 [0.79-1.09],0.3619461172699987
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],16466,240,1.00 [0.80-1.25],0.979032280840992
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Polyarthritis, unspecified",11887,60,1.13 [0.76-1.67],0.5567292748622779
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,14429,2602,0.95 [0.89-1.02],0.1743678467704834
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,12520,693,1.01 [0.89-1.15],0.878560299399013
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polymyalgia rheumatica,19077,307,0.67 [0.51-0.87],0.0031342560796243
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Postprocedural musculoskeletal disorders, not elsewhere classified",19457,60,0.94 [0.58-1.51],0.7946086182807383
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Primary gonarthrosis, bilateral",17296,58,0.90 [0.54-1.50],0.6746982969278161
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Psoriatic arthropathies,11886,59,1.06 [0.70-1.60],0.7764222431083093
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Radiculopathy,16243,89,0.98 [0.67-1.43],0.9189581040483484
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,12290,463,1.07 [0.92-1.24],0.3549636922763348
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,16506,280,1.05 [0.86-1.27],0.6470433672978452
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,16393,239,1.03 [0.82-1.28],0.8203705140771238
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Scoliosis,16365,211,0.99 [0.77-1.25],0.907838953934933
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Seronegative rheumatoid arthritis,13766,59,0.90 [0.55-1.48],0.6818115305263696
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Seropositive rheumatoid arthritis, wide",19485,62,0.91 [0.56-1.47],0.6918441038440255
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,16683,457,1.05 [0.91-1.22],0.4959920584389875
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sicca syndrome [Sj¬ögren],18855,85,0.98 [0.68-1.42],0.9184636217790976
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,18406,2180,0.99 [0.92-1.06],0.7406195002576761
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",16350,124,0.75 [0.51-1.10],0.1442350856118227
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,16715,561,1.01 [0.87-1.17],0.9258808419783472
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondyloarthritis,18346,224,0.88 [0.68-1.14],0.3377062621643393
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylolisthesis/Spondylolysis,16351,197,1.13 [0.91-1.40],0.2598166722528112
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,17772,1618,0.99 [0.91-1.08],0.8706075492336094
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,17211,1057,1.00 [0.90-1.12],0.965449730202013
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Synovial cyst of popliteal space [Baker],16273,47,1.27 [0.90-1.79],0.1783439124373318
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,18875,105,1.08 [0.80-1.47],0.6179501174004242
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,16367,141,0.90 [0.66-1.24],0.5330126367774523
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trochanteric bursitis,16306,80,0.68 [0.41-1.13],0.1336310448372205
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Wrist or foot drop (acquired),11888,61,0.78 [0.45-1.34],0.3643978412143519
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Acute renal failure,18392,1769,1.02 [0.94-1.11],0.6438798952219412
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Adenomyosis (Endometriosis of uterus),7849,23,0.87 [0.38-1.95],0.7286238130468026
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Benign mammary dysplasia,9962,27,1.19 [0.73-1.95],0.4797852773404725
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,19234,259,0.99 [0.79-1.23],0.9022076850550528
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Calculus of lower urinary tract,19062,87,1.10 [0.79-1.53],0.585045082523243
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,18339,1716,1.02 [0.94-1.11],0.5609498353047255
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Chronic nephritic syndrome,19322,87,1.06 [0.74-1.51],0.7524352881962788
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Cyst of kidney,19279,332,1.10 [0.93-1.31],0.2756088008327924
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Cystitis,16361,255,0.97 [0.77-1.22],0.7898215376247706
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Dialysis,16690,67,0.89 [0.55-1.44],0.6459761626050993
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Diseases of male genital organs,8563,1779,0.95 [0.87-1.04],0.2432214796453983
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Disorders of breast,10038,103,1.14 [0.86-1.51],0.3644460325583636
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Endometriosis,7860,34,0.92 [0.48-1.73],0.7848648689357325
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Female genital prolapse,8312,486,1.03 [0.89-1.19],0.6867070258577413
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,16125,5165,1.01 [0.96-1.05],0.8225500722019564
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Glomerular disorders in diseases classified elsewhere,19302,67,1.26 [0.90-1.76],0.1775996312262839
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Hydrocele,6884,100,0.88 [0.59-1.30],0.5202788783968049
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Hydronephrosis,16657,277,1.00 [0.81-1.23],0.997567180825462
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Hyperplasia of prostate,8297,1513,0.94 [0.86-1.04],0.2374576352784988
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of female pelvic organs,10090,139,0.77 [0.54-1.11],0.1579637211479811
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of prostate (prostatitis),6888,104,0.57 [0.34-0.94],0.0276103184848534
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,16177,71,1.20 [0.87-1.65],0.2710249756542301
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,8695,869,1.00 [0.89-1.12],0.9365137741657296
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Orchitis and epididymitis,6835,51,0.67 [0.34-1.30],0.2380793887143217
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Other abnormal uterine and vaginal bleeding,7859,33,1.09 [0.64-1.87],0.7449147589466867
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,"Other chronic cystitis, drug-induced",19496,74,1.07 [0.74-1.54],0.7261173238072972
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,"Other cystitis, drug-induced",19490,71,0.96 [0.63-1.48],0.8605151330593254
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,18507,2401,0.99 [0.93-1.07],0.8884562027747194
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,16901,795,0.98 [0.86-1.11],0.756495442665314
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Other disorders of breast,9978,43,1.20 [0.80-1.81],0.3798520633901155
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,19440,493,1.11 [0.96-1.28],0.1454437073017752
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Other disorders of male genital organs,6904,120,1.05 [0.78-1.42],0.7315689354280808
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Other disorders of penis,6917,133,0.81 [0.56-1.17],0.265686232692966
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Other disorders of prostate,6908,124,0.84 [0.58-1.21],0.348544650084755
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Other disorders of the genitourinary system,19473,69,0.81 [0.49-1.33],0.4034883853012637
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,17976,1870,0.99 [0.91-1.08],0.8287556374234142
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Other female pelvic inflammatory diseases,10023,72,0.72 [0.43-1.21],0.2119314916351844
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,7891,65,1.20 [0.86-1.66],0.2775218262944272
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,"Other noninflammatory disorders of uterus, except cervix",7958,132,0.92 [0.67-1.27],0.6037026926449229
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vagina,7874,48,0.88 [0.51-1.50],0.6313846240506722
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vulva and perineum,7912,86,0.73 [0.46-1.17],0.1905331194322914
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,16706,326,1.05 [0.88-1.26],0.6001190928044252
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Other specified disorders of kidney and ureter,19106,159,1.17 [0.93-1.47],0.1714211219228831
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Ovarian cyst,7931,105,1.02 [0.74-1.40],0.897857104106773
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Pain and other conditions associated with female genital organs and menstrual cycle,7846,20,0.91 [0.40-2.06],0.8185425393179135
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Polyp of the female genital tract,8007,181,0.83 [0.62-1.12],0.2234290968879141
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Postmenopausal atrophic vaginitis,7907,81,0.86 [0.56-1.32],0.4952009054695153
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Postmenopausal bleeding,8003,177,0.96 [0.74-1.25],0.7578672257018453
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Recurrent and persistent haematuria,19280,45,0.68 [0.34-1.36],0.2724685954523441
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,"Redundant prepuce, phimosis and paraphimosis",6911,127,0.94 [0.67-1.32],0.7146492224235006
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,19297,2917,1.02 [0.96-1.09],0.5176992264914957
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,"Tubulo-interstitial nephritis, not specified as acute or chronic",16452,72,1.19 [0.87-1.63],0.2818634146514787
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,16761,138,1.02 [0.76-1.37],0.9144264520120672
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,19009,34,0.93 [0.50-1.75],0.8319073279784119
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Urethral stricture,16333,227,1.11 [0.90-1.36],0.3384447442121377
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Urolithiasis,19309,334,1.05 [0.88-1.26],0.5901842254367442
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Uterine polyps,7858,32,0.60 [0.26-1.42],0.2453471083634298
